IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors

Published:2015-05-12 Issue:10 Volume:87 Page:1702-1715
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Olmedo Daniele Blasquez¹,Cader Samária Ali¹,Porto Luís Cristóvão¹

Affiliation:

1. Histocompatibility and Cryopreservation Laboratory; Rio de Janeiro State University; Rio de Janeiro Brazil

Funder

Carlos Chagas Filho Research Foundation of the Rio de Janeiro State (FAPERJ)

Brazilian Council for Scientific and Technologic Development (CNPq)

Education Ministry (CAPES-Pro-Ensino na Saúde)

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.24227/fullpdf

Reference89 articles.

1. IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy;Abe;J Hepatol,2011

2. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6;Akkarathamrongsin;J Med Virol,2014

3. Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection;Alestig;BMC Infect Dis,2011

4. High predictability of a sustained virological response (87%) in chronic hepatitis C virus genotype 1 infection treatment by combined IL28B genotype analysis and gamma-glutamyltransferase/alanine aminotransferase ratio: a retrospective single-center study;Amanzada;Digestion,2012a

5. Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1;Amanzada;J Med Virol,2012b

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon-λ orchestrates innate and adaptive mucosal immune responses;Nature Reviews Immunology;2019-06-14

2. Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients;Disease Markers;2018-08-14

3. A systematic review and meta-analysis of HCV clearance;Liver International;2017-03-30

4. Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals;Pharmacogenomics and Personalized Medicine;2017-03

5. Personalized Medicine for Hepatitis C Virus;Diagnostic Molecular Pathology;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3